Stay Up to Date
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
October 30, 2023
Reflections From Jeanne Whiting, Our Retiring Executive Director And DTRF’s Co-Founder
October 1, 2023
Ten New ICD-10-CM Diagnosis Codes For Desmoid Tumors Go Into Effect on October 1, 2023, in the United States.
September 30, 2023
Desmoid Tumor Awareness Month 2023 Comes To A Close
Read More about Desmoid Tumor Awareness Month 2023 Comes To A Close
September 26, 2023
DTRF Press Release: The Desmoid Tumor Research Foundation Announces That Groundbreaking Results From The Phase 3 Springworks Defi Trial Were Published Today In The New England Journal Of Medicine (More)
June 12, 2023
Coverage of Desmoid Tumors at ASCO 2023
May 21, 2023
Top 5 Reasons To Attend The Annual DTRF Together We Will Weekend
Read More about Top 5 Reasons To Attend The Annual DTRF Together We Will Weekend
